FDA recall D-0232-2022

Teva Pharmaceuticals USA · Class II · drug

Product

Cartia XT (Diltiazem Hydrochloride Extended-Release Capsules, USP) 120 mg, Rx Only, 90 capsules, labelled as (a) Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054; (b) Manufactured By: Actavis Laboratories FL. Inc, Fort Lauderdale FL. 33314 USA, Distributed by Avista Pharma Inc. Parsippany, NJ 07054 USA. NDC 62037-597-90

Reason for recall

Labelling: Incorrect Exp. Date

Distribution

Distributed Nationwide in the USA

Key facts

Status
Terminated
Initiation date
2021-10-27
Report date
2021-11-24
Termination date
2022-12-21
Voluntary/Mandated
Voluntary: Firm initiated
Location
Parsippany, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0232-2022